“Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin As a Novel Therapeutic Approach”. Asian Journal of Diabetology, vol. 25, no. 1, Aug. 2025, pp. 7-21, https://doi.org/10.59793/0vmn8208.